Venus Concept Inc (Venus) is a medical device company that develops and manufactures non-invasive aesthetic equipment. the company offers aesthetic devices such as venus swan, a non-invasive body contouring device used for reducing wrinkles, cellulite and circumferential fat reduction and tightening of the skin. It provides venus viva for facial remodeling and resurfacing, venus versa for skin restoration and texture and venus legacy, a workstation that offers body contouring, skin tightening and wrinkle reduction. Venus offers technical support and clinical support services. Its brands include ARTAS iXi, NeoGraft, Venus Velocity and Venus Epileve, among others. The company operates globally. Venus is headquartered in Toronto, Ontario, Canada.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Venus Concept Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Venus Concept Inc Company Overview
Venus Concept Inc Company Snapshot
Venus Concept Inc Pipeline Products and Ongoing Clinical Trials Overview
Venus Concept Inc – Pipeline Analysis Overview
Venus Concept Inc - Key Facts
Venus Concept Inc - Major Products and Services
Venus Concept Inc Pipeline Products by Development Stage
Venus Concept Inc Ongoing Clinical Trials by Trial Status
Venus Concept Inc Pipeline Products Overview
AI.ME Robotic System
AI.ME Robotic System Product Overview
Venus Aime
Venus Aime Product Overview
Venus Aime Clinical Trial
Venus Aime - Tissue Excision
Venus Aime - Tissue Excision Product Overview
Venus Concept Inc - Key Competitors
Venus Concept Inc - Key Employees
Venus Concept Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Venus Concept Inc, Recent Developments
Feb 06, 2024: Venus Concept to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13th
Jan 24, 2024: Venus Concept Announces Review of Strategic Alternatives
Jan 17, 2024: Venus Concept Launches Venus Prime
Dec 18, 2023: Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth
Nov 14, 2023: Venus Concept Announces Third Quarter of Fiscal Year 2023 Financial Results
Nov 01, 2023: Venus Concept Launches Venus Versa Pro, Its New Multi-Application Platform for Face and Body Treatments
Oct 12, 2023: Venus Concept Appoints Dr. Hemanth Varghese as President and Chief Operating Officer and Industry Veteran to Lead International Operations
Oct 05, 2023: Venus Concept Announces Debt Restructuring, Preliminary Third Quarter 2023 Revenue Results and Updates Fiscal Year 2023 Revenue Guidance
Sep 14, 2023: Venus Concept Receives 510(k) Clearance for the Venus Versa Pro System, Its New Multi-Application Platform
Sep 06, 2023: Venus Concept to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Table 11: AI.ME Robotic System - Product Description
Table 12: Venus Aime - Product Status
Table 13: Venus Aime - Product Description
Table 14: Venus Aime - Clinical Evaluation of the Safety and Efficacy of Aime Robotic Mechanical Coring Device for the Treatment of Moderate to Severe Facial Wrinkles
Table 15: Venus Aime - Pilot Study for the Clinical Evaluation of Mechanical Coring to Achieve Directional Skin Tightening
Table 16: Venus Aime - Tissue Excision - Product Status